-transparent.png){kind=logo}
The synthetic ACTH 4-9 analog, Org 2766, was administered to 77 Alzheimer's patients for 6 months in a double-blind, placebo-controlled study. Although Org 2766 was tolerated well, no significant effect of Org 2766 could be demonstrated in terms of rating scales or cognitive functions.
Related Publications
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
June 1993,
Journal of clinical psychopharmacology,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
June 1979,
Pharmacology, biochemistry, and behavior,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
February 1982,
European journal of pharmacology,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
October 1984,
Pharmacology, biochemistry, and behavior,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
June 1985,
Life sciences,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
January 1991,
Annals of the New York Academy of Sciences,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
July 1991,
Behavioural brain research,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
January 1989,
Psychopharmacology bulletin,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
May 1983,
Life sciences,
H Soininen, and
T Koskinen, and
E L Helkala, and
R Pigache, and
P J Riekkinen
January 1984,
Progress in neuro-psychopharmacology & biological psychiatry,
